Sodium hydride → Fenazaquin

HRID 35836

反応式

HRID 35836 の反応式
[H-].[Na+].[C:3]([C:7]1[CH:12]=[CH:11][C:10]([CH2:13][CH2:14][OH:15])=[CH:9][CH:8]=1)([CH3:6])([CH3:5])[CH3:4].Cl[C:17]1[C:26]2[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=2)[N:20]=[CH:19][N:18]=1>CN(C=O)C.O>[C:3]([C:7]1[CH:8]=[CH:9][C:10]([CH2:13][CH2:14][O:15][C:17]2[C:26]3[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=3)[N:20]=[CH:19][N:18]=2)=[CH:11][CH:12]=1)([CH3:6])([CH3:4])[CH3:5]

参加物

6

反応物 3

HCID 24758Sodium hydrideHCID 788644-ChloroquinazolineHCID 79410p-tert-Butylphenethyl alcohol

生成物 1

HCID 86356Fenazaquin収率 28.4%

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒2 回

実験手順

To a solution of 1.1 g of sodium hydride in 50 ml of DMF, 4.0 g of 2-[4-(t-butyl)phenyl]ethanol was added, and the mixture was stirred at room temperature for one hour. Then 3.6 g of 4-chloroquinazoline in 20 ml of DMF were added, and the mixture was stirred at room temperature overnight. The mixture was then poured into a mixture of ice in water. The product was extracted into CH2Cl2, and the resulting solution was concentrated to dryness. TLC showed one major spot and five minor spots. The product was purified by HPLC (silica gel, CH2Cl2). The fractions containing the major product were collected and concentrated, giving 1.9 g of the title product. Yield: 28.4%. M.P. 70°-71° C.

後処理

  1. stirringthe mixture was stirred at room temperature overnight
  2. extractionThe product was extracted into CH2Cl2
  3. concentrationthe resulting solution was concentrated to dryness
  4. customThe product was purified by HPLC (silica gel, CH2Cl2)
  5. additionThe fractions containing the major product
  6. customwere collected
  7. concentrationconcentrated

出典と根拠

ORDレコード
ord-378409998bb94c5480b3bbf142ebb392
出典データセット
uspto-grants-1995_05
特許番号
US05411963

関連ノート

読み込み中…